Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Functional Impairment in Youth With ADHD: Normative Data and Norm-Referenced Cutoff Points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale, Revised.

Faraone SV, DeSousa NJ, Komolova M, Sallee FR, Incledon B, Wilens TE.

J Clin Psychiatry. 2019 Dec 10;81(1). pii: 19m12956. doi: 10.4088/JCP.19m12956.

2.

An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations.

Childress AC, Komolova M, Sallee FR.

Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):937-974. doi: 10.1080/17425255.2019.1675636. Epub 2019 Nov 8. Review.

PMID:
31581854
3.

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.

Childress AC, Cutler AJ, Marraffino A, McDonnell MA, Turnbow JM, Brams M, DeSousa NJ, Incledon B, Sallee FR, Wigal SB.

J Child Adolesc Psychopharmacol. 2020 Feb;30(1):2-14. doi: 10.1089/cap.2019.0070. Epub 2019 Aug 29.

4.

Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults.

Liu T, Gobburu JVS, Po MD, McLean A, DeSousa NJ, Sallee FR, Incledon B.

J Child Adolesc Psychopharmacol. 2019 Apr;29(3):181-191. doi: 10.1089/cap.2018.0122. Epub 2019 Feb 27.

5.

The Expansion Segments of 28S Ribosomal RNA Extensively Match Human Messenger RNAs.

Parker MS, Balasubramaniam A, Sallee FR, Parker SL.

Front Genet. 2018 Mar 7;9:66. doi: 10.3389/fgene.2018.00066. eCollection 2018.

6.

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.

Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, López FA, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH.

J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21.

7.

Cue-dependent inhibition in posttraumatic stress disorder and attention-deficit/hyperactivity disorder.

Adams ZW, Meinzer M, Mandel H, Voltin J, Caughron B, Sallee FR, Hamner M, Wang Z.

J Anxiety Disord. 2017 Oct;51:1-6. doi: 10.1016/j.janxdis.2017.08.003. Epub 2017 Aug 9.

PMID:
28818658
8.

Canonical microRNA Matching Differs Greatly Across Groups of G-protein Coupled Receptor mRNAs.

Parker MS, Balasubramaniam A, Sallee FR, Parker SL.

Microrna. 2017 Dec 6;6(3):187-199. doi: 10.2174/2211536606666170804162421.

PMID:
28782472
9.

Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder.

Sallee FR, Palumbo DR, Abbas R, Berry SA, Puthli SP, Kathala KK.

Clin Pharmacol Drug Dev. 2017 Sep;6(5):476-483. doi: 10.1002/cpdd.366. Epub 2017 Jun 19.

PMID:
28628269
10.

Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.

Faraone SV, Schachar RJ, Barkley RA, Nullmeier R, Sallee FR.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):715-722. doi: 10.1089/cap.2016.0164. Epub 2017 Apr 10.

11.

Canonical Matches of Human MicroRNAs with mRNAs: A Broad Matrix of Position and Size.

Parker MS, Park EA, Sallee FR, Parker SL.

Microrna. 2016;5(3):211-221.

PMID:
27834138
12.

Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.

Faraone SV, Childress A, Wigal SB, Kollins SH, McDonnell MA, DeSousa NJ, Sallee FR.

J Atten Disord. 2018 Sep;22(11):1066-1073. doi: 10.1177/1087054715619009. Epub 2015 Dec 23.

PMID:
26700792
13.

Homoiterons and expansion in ribosomal RNAs.

Parker MS, Sallee FR, Park EA, Parker SL.

FEBS Open Bio. 2015 Oct 23;5:864-76. doi: 10.1016/j.fob.2015.10.005. eCollection 2015.

14.

G and C Iterons and Strings in MicroRNAs Should be Important in Regulation of mRNAs(†).

Parker MS, Park EA, Sallee FR, Parker SL.

Microrna. 2015;4(3):175-84.

PMID:
26467633
15.

Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.

Childress AC, Sallee FR.

CNS Drugs. 2015 Aug;29(8):683-93. doi: 10.1007/s40263-015-0264-9. Review.

PMID:
26267739
16.

Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.

Sallee FR.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):558-65. doi: 10.1089/cap.2014.0160. Epub 2015 Jul 7.

17.

Child/Adolescent Anxiety Multimodal Study safety.

Sallee FR.

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):162-3. doi: 10.1016/j.jaac.2014.12.009. No abstract available.

PMID:
25721180
18.

Pozanicline for the treatment of attention-deficit/hyperactivity disorder.

Childress A, Sallee FR.

Expert Opin Investig Drugs. 2014 Nov;23(11):1585-93. doi: 10.1517/13543784.2014.956078. Epub 2014 Sep 6. Review.

PMID:
25196198
19.

Dimers of G-protein coupled receptors as versatile storage and response units.

Parker MS, Sah R, Balasubramaniam A, Park EA, Sallee FR, Parker SL.

Int J Mol Sci. 2014 Mar 19;15(3):4856-77. doi: 10.3390/ijms15034856.

20.

On the expansion of ribosomal proteins and RNAs in eukaryotes.

Parker MS, Sah R, Balasubramaniam A, Sallee FR, Park EA, Parker SL.

Amino Acids. 2014 Jul;46(7):1589-604. doi: 10.1007/s00726-014-1704-4. Epub 2014 Mar 15.

PMID:
24633358
21.

Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD).

Chen TH, Wu SW, Welge JA, Dixon SG, Shahana N, Huddleston DA, Sarvis AR, Sallee FR, Gilbert DL.

J Child Neurol. 2014 Dec;29(12):1672-9. doi: 10.1177/0883073813513333. Epub 2014 Jan 10.

22.

Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.

Childress AC, Sallee FR.

CNS Drugs. 2014 Feb;28(2):121-9. doi: 10.1007/s40263-013-0130-6. Review.

PMID:
24402970
23.

Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.

Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA.

Clin Ther. 2013 Nov;35(11):1778-93. doi: 10.1016/j.clinthera.2013.09.005. Epub 2013 Oct 16. Review.

PMID:
24139092
24.

The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.

Childress A, Sallee FR.

Expert Rev Neurother. 2013 Sep;13(9):979-88. doi: 10.1586/14737175.2013.833002. Review.

PMID:
24053342
25.

The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.

Müller TD, Müller A, Yi CX, Habegger KM, Meyer CW, Gaylinn BD, Finan B, Heppner K, Trivedi C, Bielohuby M, Abplanalp W, Meyer F, Piechowski CL, Pratzka J, Stemmer K, Holland J, Hembree J, Bhardwaj N, Raver C, Ottaway N, Krishna R, Sah R, Sallee FR, Woods SC, Perez-Tilve D, Bidlingmaier M, Thorner MO, Krude H, Smiley D, DiMarchi R, Hofmann S, Pfluger PT, Kleinau G, Biebermann H, Tschöp MH.

Nat Commun. 2013;4:1968. doi: 10.1038/ncomms2968.

26.

Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.

Sallee FR, Kollins SH, Wigal TL.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):206-14. doi: 10.1089/cap.2010.0135. Epub 2012 May 21.

27.

Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.

Childress AC, Sallee FR.

Drugs Today (Barc). 2012 Mar;48(3):207-17. doi: 10.1358/dot.2012.48.3.1750904. Review.

PMID:
22462040
28.

The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

Hodgkins P, Shaw M, McCarthy S, Sallee FR.

CNS Drugs. 2012 Mar 1;26(3):245-68. doi: 10.2165/11599630-000000000-00000. Review.

PMID:
22329564
29.

The use of lisdexamfetamine dimesylate for the treatment of ADHD.

Childress AC, Sallee FR.

Expert Rev Neurother. 2012 Jan;12(1):13-26. doi: 10.1586/ern.11.175. Review.

PMID:
22243042
30.

Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress.

McGuire JL, Larke LE, Sallee FR, Herman JP, Sah R.

Front Behav Neurosci. 2011 Sep 15;5:54. doi: 10.3389/fnbeh.2011.00054. eCollection 2011.

31.

Single-dose pharmacokinetics of NWP06, an extended-release methylphenidate suspension, in children and adolescents with ADHD.

Childress AC, Sallee FR, Berry SA.

Postgrad Med. 2011 Sep;123(5):80-8. doi: 10.3810/pgm.2011.09.2462.

PMID:
21904089
32.

Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.

Parker MS, Sah R, Balasubramaniam A, Sallee FR, Zerbe O, Parker SL.

Peptides. 2011 Feb;32(2):258-65. doi: 10.1016/j.peptides.2010.11.018. Epub 2010 Nov 30.

33.

The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

Sallee FR.

Postgrad Med. 2010 Sep;122(5):78-87. doi: 10.3810/pgm.2010.09.2204. Review.

PMID:
20861591
34.

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).

Sallee FR, Eaton K.

Expert Opin Pharmacother. 2010 Oct;11(15):2549-56. doi: 10.1517/14656566.2010.517523. Review.

PMID:
20831361
35.

Enhanced fear recall and emotional arousal in rats recovering from chronic variable stress.

McGuire J, Herman JP, Horn PS, Sallee FR, Sah R.

Physiol Behav. 2010 Nov 2;101(4):474-82. doi: 10.1016/j.physbeh.2010.07.013. Epub 2010 Aug 3.

36.

Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers.

Estes AM, McAllen K, Parker MS, Sah R, Sweatman T, Park EA, Balasubramaniam A, Sallee FR, Walker MW, Parker SL.

Amino Acids. 2011 Feb;40(2):371-80. doi: 10.1007/s00726-010-0642-z. Epub 2010 Jun 25.

PMID:
20577889
37.

Two intracellular helices of G-protein coupling receptors could generally support oligomerization and coupling with transducers.

Parker MS, Park EA, Sallee FR, Parker SL.

Amino Acids. 2011 Feb;40(2):261-8. doi: 10.1007/s00726-010-0616-1. Epub 2010 Jun 23. Review.

PMID:
20571842
38.

Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.

Cannon M, Pelham WH, Sallee FR, Palumbo DR, Bukstein O, Daviss WB.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):511-7. doi: 10.1089/cap.2009.0008.

39.

An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.

Findling RL, Kauffman R, Sallee FR, Salazar DE, Sahasrabudhe V, Kollia G, Kornhauser DM, Vachharajani NN, Assuncao-Talbott S, Mallikaarjun S, Iwamoto T, McQuade RD, Boulton DW, Blumer J.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):431-9. doi: 10.1089/cap.2008.0111.

PMID:
19702495
40.

Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder.

Sah R, Ekhator NN, Strawn JR, Sallee FR, Baker DG, Horn PS, Geracioti TD Jr.

Biol Psychiatry. 2009 Oct 1;66(7):705-7. doi: 10.1016/j.biopsych.2009.04.037. Epub 2009 Jul 3.

41.

Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Sallee FR, Lyne A, Wigal T, McGough JJ.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):215-26. doi: 10.1089/cap.2008.0080.

PMID:
19519256
42.

Acid-sensing by the T cell death-associated gene 8 (TDAG8) receptor cloned from rat brain.

McGuire J, Herman JP, Ghosal S, Eaton K, Sallee FR, Sah R.

Biochem Biophys Res Commun. 2009 Aug 28;386(3):420-5. doi: 10.1016/j.bbrc.2009.05.133. Epub 2009 Jun 6.

43.

Oligomerization of the heptahelical G protein coupling receptors: a case for association using transmembrane helices.

Parker MS, Sah R, Park EA, Sweatman T, Balasubramaniam A, Sallee FR, Parker SL.

Mini Rev Med Chem. 2009 Mar;9(3):329-39. Review.

PMID:
19275726
44.

Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.

Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J; SPD503 STUDY GROUP.

J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):155-65. doi: 10.1097/CHI.0b013e318191769e.

PMID:
19106767
45.

Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association with G proteins.

Parker MS, Sah R, Balasubramaniam A, Sallee FR, Sweatman T, Park EA, Parker SL.

J Recept Signal Transduct Res. 2008;28(5):437-51. doi: 10.1080/10799890802447423 .

PMID:
18946765
46.

Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.

Findling RL, Kauffman RE, Sallee FR, Carson WH, Nyilas M, Mallikaarjun S, Shoaf SE, Forbes RA, Boulton DW, Pikalov A.

J Clin Psychopharmacol. 2008 Aug;28(4):441-6. doi: 10.1097/JCP.0b013e31817dd520.

PMID:
18626272
47.

Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric.

Estes AM, Wong YY, Parker MS, Sallee FR, Balasubramaniam A, Parker SL.

Regul Pept. 2008 Oct 9;150(1-3):88-94. doi: 10.1016/j.regpep.2008.06.002. Epub 2008 Jun 10.

PMID:
18585408
48.

The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain.

Parker SL, Parker MS, Estes AM, Wong YY, Sah R, Sweatman T, Park EA, Balasubramaniam A, Sallee FR.

J Recept Signal Transduct Res. 2008;28(3):245-63. doi: 10.1080/10799890802084341 .

PMID:
18569526
49.

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.

Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.

J Clin Psychiatry. 2008 Jan;69(1):149-59. Erratum in: J Clin Psychiatry. 2008 Feb;69(2):329.

PMID:
18312050
50.

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.

Daviss WB, Patel NC, Robb AS, McDERMOTT MP, Bukstein OG, Pelham WE Jr, Palumbo D, Harris P, Sallee FR; CAT STUDY TEAM.

J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):189-198. doi: 10.1097/chi.0b013e31815d9ae4.

PMID:
18182964

Supplemental Content

Loading ...
Support Center